Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival

The prognosis of children with metastatic neuroblastoma (NB) > 18 months at diagnosis is dismal. Since the immune status of the tumor microenvironment could play a role in the history of disease, we evaluated the expression of CD45, CD14, ARG1, CD163, CD4, FOXP3, Perforin-1 (PRF1), Granzyme B (GR...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Biomed Res Int
Auteurs principaux: Stigliani, Sara, Croce, Michela, Morandi, Fabio, Scaruffi, Paola, Rigo, Valentina, Carlini, Barbara, Manzitti, Carla, Gigliotti, Anna Rita, Tonini, Gian Paolo, Pistoia, Vito, Ferrini, Silvano, Corrias, Maria Valeria
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2015
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4486282/
https://ncbi.nlm.nih.gov/pubmed/26161395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/347867
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires